15-36657751-T-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001321759.2(CDIN1):c.274-82T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.96 in 1,068,884 control chromosomes in the GnomAD database, including 492,603 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.95 ( 69361 hom., cov: 31)
Exomes 𝑓: 0.96 ( 423242 hom. )
Consequence
CDIN1
NM_001321759.2 intron
NM_001321759.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.237
Genes affected
CDIN1 (HGNC:26929): (CDAN1 interacting nuclease 1) This gene encodes a protein with two predicted helix-turn-helix domains. Mutations in this gene were found in families with congenital dyserythropoietic anemia type Ib. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 15-36657751-T-A is Benign according to our data. Variant chr15-36657751-T-A is described in ClinVar as [Benign]. Clinvar id is 1192629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDIN1 | NM_001321759.2 | c.274-82T>A | intron_variant | Intron 4 of 10 | ENST00000566621.6 | NP_001308688.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.955 AC: 145204AN: 152092Hom.: 69321 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
145204
AN:
152092
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.961 AC: 880717AN: 916674Hom.: 423242 AF XY: 0.960 AC XY: 446817AN XY: 465314 show subpopulations
GnomAD4 exome
AF:
AC:
880717
AN:
916674
Hom.:
AF XY:
AC XY:
446817
AN XY:
465314
show subpopulations
African (AFR)
AF:
AC:
19842
AN:
21130
American (AMR)
AF:
AC:
28383
AN:
29332
Ashkenazi Jewish (ASJ)
AF:
AC:
20052
AN:
20892
East Asian (EAS)
AF:
AC:
32852
AN:
32878
South Asian (SAS)
AF:
AC:
59091
AN:
62010
European-Finnish (FIN)
AF:
AC:
47623
AN:
48278
Middle Eastern (MID)
AF:
AC:
4458
AN:
4646
European-Non Finnish (NFE)
AF:
AC:
628818
AN:
656036
Other (OTH)
AF:
AC:
39598
AN:
41472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1618
3236
4855
6473
8091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.955 AC: 145301AN: 152210Hom.: 69361 Cov.: 31 AF XY: 0.957 AC XY: 71208AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
145301
AN:
152210
Hom.:
Cov.:
31
AF XY:
AC XY:
71208
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
38912
AN:
41542
American (AMR)
AF:
AC:
14565
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
3328
AN:
3470
East Asian (EAS)
AF:
AC:
5173
AN:
5180
South Asian (SAS)
AF:
AC:
4570
AN:
4820
European-Finnish (FIN)
AF:
AC:
10498
AN:
10620
Middle Eastern (MID)
AF:
AC:
279
AN:
294
European-Non Finnish (NFE)
AF:
AC:
65108
AN:
67970
Other (OTH)
AF:
AC:
2009
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
351
702
1052
1403
1754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3300
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Congenital dyserythropoietic anemia type type 1B Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
Loading publications...